BRETHINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Brethine, and what generic alternatives are available?
Brethine is a drug marketed by Pharmacare and Ani Pharms and is included in two NDAs.
The generic ingredient in BRETHINE is terbutaline sulfate. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brethine
A generic version of BRETHINE was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRETHINE?
- What are the global sales for BRETHINE?
- What is Average Wholesale Price for BRETHINE?
Summary for BRETHINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Clinical Trials: | 2 |
Patent Applications: | 3,693 |
DailyMed Link: | BRETHINE at DailyMed |
Recent Clinical Trials for BRETHINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yaakov Beilin | Phase 2/Phase 3 |
Jaeb Center for Health Research | Phase 1 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 |
US Patents and Regulatory Information for BRETHINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacare | BRETHINE | terbutaline sulfate | INJECTABLE;INJECTION | 018571-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRETHINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacare | BRETHINE | terbutaline sulfate | INJECTABLE;INJECTION | 018571-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pharmacare | BRETHINE | terbutaline sulfate | INJECTABLE;INJECTION | 018571-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BRETHINE
See the table below for patents covering BRETHINE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1643296 | ⤷ Sign Up | |
Norway | 132866 | ⤷ Sign Up | |
Norway | 124723 | ⤷ Sign Up | |
Switzerland | 512428 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen | ⤷ Sign Up |
Switzerland | 510625 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen (1-3 5-dihydroxyphenyl-2-alkylaminoethanols) | ⤷ Sign Up |
Switzerland | 510627 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxyphenyl)-2-cyclobutylaminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |